According to the Global Cancer Observatory, ovarian cancer was the third most common cancer among women in India in 2022, ...

When it comes to ovarian cancer, early detection plays a crucial role in improving survival rates. Catching the disease in ...

Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...

The Wistar Institute's Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center's Molecular and ...

The Fussell family has been committed to changing the future of ovarian cancer, ever since hearing Professor Anna deFazio AM ...

The following is a summary of “CD1a affects the recurrence and prognosis of ovarian cancer,” published in the November 2024 ...

You have the power to save lives by funding a public awareness campaign which would help women to spot the signs" ...

A retrospective study found that younger patients with ER-positive, ERBB2-negative breast cancer are more prone to late ...

The European Commission has approved mirvetuximab soravtansine for select patients with pretreated folate receptor–alpha (FRα)-positive, platinum-resistant ovarian cancer.

“Our work has opened the door to a possible new method of treating a particularly aggressive cancer,” said Brennah Murphy, Ph.D., first author of the paper. “Ovarian cancer is infamous for resisting ...

FDA Project Team supports the company’s proposed Phase 3 trial strategy, including overall trial design, target patient population, treatment ...